Related references
Note: Only part of the references are listed.Transforming Cancer Prevention through Precision Medicine and Immune-oncology
Thomas W. Kensler et al.
CANCER PREVENTION RESEARCH (2016)
Inherited Mutations in Women With Ovarian Carcinoma
Barbara M. Norquist et al.
JAMA ONCOLOGY (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Cancer precursor lesions in the BRCA population at the time of prophylactic salpingo-oophorectomy: Accuracy of assessment and potential surrogate marker for prevention
Stephanie Lheureux et al.
GYNECOLOGIC ONCOLOGY (2015)
Why have ovarian cancer mortality rates declined? Part I. Incidence
Victoria Sopik et al.
GYNECOLOGIC ONCOLOGY (2015)
Cancer of the ovary, fallopian tube, and peritoneum
Jonathan S. Berek et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2015)
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
David D. Bowtell et al.
NATURE REVIEWS CANCER (2015)
Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention
Jessica N. McAlpine et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2014)
The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas
M. R. Akbari et al.
CLINICAL GENETICS (2014)
Comparison of risk management strategies between women testing positive for a BRCA variant of unknown significance and women with known BRCA deleterious mutations
Christine Garcia et al.
GENETICS IN MEDICINE (2014)
A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers
Ilana Cass et al.
GYNECOLOGIC ONCOLOGY (2014)
Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers
Laura L. Holman et al.
GYNECOLOGIC ONCOLOGY (2014)
Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations
James R. Conner et al.
GYNECOLOGIC ONCOLOGY (2014)
Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
Amy P. M. Finch et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Pathologic Findings at Risk-Reducing Salpingo-Oophorectomy: Primary Results From Gynecologic Oncology Group Trial GOG-0199
Mark E. Sherman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drug, and Acetaminophen Use and Risk of Invasive Epithelial Ovarian Cancer: A Pooled Analysis in the Ovarian Cancer Association Consortium
Britton Trabert et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma
Anca Milea et al.
MODERN PATHOLOGY (2014)
BRCA and early evens in the development of serous ovarian cancer
Sophia H. L. George et al.
FRONTIERS IN ONCOLOGY (2014)
Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
Ruth Perets et al.
CANCER CELL (2013)
Salpingectomy to prevent ovarian cancer
S. A. Narod
CURRENT ONCOLOGY (2013)
Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens
Welmoed Reitsma et al.
EUROPEAN JOURNAL OF CANCER (2013)
Global ovarian cancer health disparities
Ganna Chornokur et al.
GYNECOLOGIC ONCOLOGY (2013)
Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy
C. B. Powell et al.
GYNECOLOGIC ONCOLOGY (2013)
Fallopian tube precursors of ovarian low- and high-grade serous neoplasms
Russell Vang et al.
HISTOPATHOLOGY (2013)
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies
Weiva Sieh et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)
Clinical Outcome of Isolated Serous Tubal Intraepithelial Carcinomas (STIC)
Stephanie L. Wethington et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Long-Term Mortality Associated With Oophorectomy Compared With Ovarian Conservation in the Nurses' Health Study
William H. Parker et al.
OBSTETRICS AND GYNECOLOGY (2013)
Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer A Systematic Review and Meta-analysis
Laura J. Havrilesky et al.
OBSTETRICS AND GYNECOLOGY (2013)
Screening for Ovarian Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement
Virginia A. Moyer
ANNALS OF INTERNAL MEDICINE (2012)
Prolonged Postovulatory Proinflammatory Signaling in the Fallopian Tube Epithelium May Be Mediated through a BRCA1/DAB2 Axis
Alicia A. Tone et al.
CLINICAL CANCER RESEARCH (2012)
Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls
Marjanka J. J. M. Mingels et al.
GYNECOLOGIC ONCOLOGY (2012)
TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions
Elisabetta Kuhn et al.
JOURNAL OF PATHOLOGY (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis
Megan S. Rice et al.
JOURNAL OF OVARIAN RESEARCH (2012)
Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status
R. Manchanda et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2011)
A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas
Talia Donenberg et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Tubal ligation and the risk of ovarian cancer: review and meta-analysis
D. Cibula et al.
HUMAN REPRODUCTION UPDATE (2011)
Risk-Reducing Salpingo-Oophorectomy (RRSO) in BRCA Mutation Carriers Experience With a Consecutive Series of 111 Patients Using a Standardized Surgical-Pathological Protocol
C. Bethan Powell et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Identification of abrogated pathways in fallopian tube epithelium from BRCA1 mutation carriers
Sophia H. L. George et al.
JOURNAL OF PATHOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Modeling high-grade serous ovarian carcinogenesis from the fallopian tube
Alison M. Karst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
Tom Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers
Danielle Vicus et al.
GYNECOLOGIC ONCOLOGY (2010)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Personalizing Therapy for Ovarian Cancer: BRCAness and Beyond
Robert C. Bast et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube
Eleanor Y. Chen et al.
JOURNAL OF PATHOLOGY (2010)
High Rates of Occult Fallopian Tube Cancer Diagnosed at Prophylactic Bilateral Salpingo-Oophorectomy
Jane E. Hirst et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
Timothy R. Rebbeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers
Patricia A. Shaw et al.
MODERN PATHOLOGY (2009)
Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses' Health Study
William H. Parker et al.
OBSTETRICS AND GYNECOLOGY (2009)
Conditional Inactivation of Brca1, p53 and Rb in Mouse Ovaries Results in the Development of Leiomyosarcomas
Katherine V. Clark-Knowles et al.
PLOS ONE (2009)
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
Joshua Z. Press et al.
BMC CANCER (2008)
Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma
Alicia A. Tone et al.
CLINICAL CANCER RESEARCH (2008)
A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
Ann K. Folkins et al.
GYNECOLOGIC ONCOLOGY (2008)
Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective
E. A. Jarboe et al.
HISTOPATHOLOGY (2008)
The cell of origin of ovarian epithelial tumours
Louis Dubeau
LANCET ONCOLOGY (2008)
Primary Fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction
Michael J. Callahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions -: Report of 6 cases and review of the literature
Maria L. Carcangiu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
BRCA1 promoter methylation predicts adverse ovarian cancer prognosis
Jing Wang Chiang et al.
GYNECOLOGIC ONCOLOGY (2006)
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome
F Medeiros et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers
A Finch et al.
GYNECOLOGIC ONCOLOGY (2006)
Advances in the recognition of tubal intraepithelial carcinoma - Applications to cancer screening and the pathogenesis of ovarian cancer
Y Lee et al.
ADVANCES IN ANATOMIC PATHOLOGY (2006)
Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention
M Sogaard et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2006)
Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: Role of serial sectioning in the detection of occult malignancy
CB Powell et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up
RI Olivier et al.
BRITISH JOURNAL OF CANCER (2004)
Hallmarks of 'BRCAness' in sporadic cancers
N Turner et al.
NATURE REVIEWS CANCER (2004)
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
MC King et al.
SCIENCE (2003)
Women harboring BRCA1/2 germline mutations are at risk for breast and female adnexal carcinoma
JMJ Piek et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Pathologic findings in prophylactic oophorectomy specimens in high-risk women
K Leeper et al.
GYNECOLOGIC ONCOLOGY (2002)
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
TR Rebbeck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
JMJ Piek et al.
JOURNAL OF PATHOLOGY (2001)
Occult carcinoma in prophylactic oophorectomy specimens - Prevalence and association with BRCA germline mutation status
TJ Colgan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations:: a case-control study
SA Narod et al.
LANCET (2001)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
